Ezra Cohen to Bortezomib
This is a "connection" page, showing publications Ezra Cohen has written about Bortezomib.
Novel molecular targeted therapies for refractory thyroid cancer. Head Neck. 2012 May; 34(5):736-45.
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.